Home › Funds › Crawford Fund Management, LLC › MRNA

Crawford Fund Management, LLC position in MRNA

MODERNA INC · Health Care

Crawford Fund Management, LLC reported holding 79,300 shares of MRNA (MODERNA INC) in its Q3 2026 13F filing — a position valued at US$15.3M, representing 2.46% of its reported portfolio and ranking #8 among its reported holdings. Crawford Fund Management, LLC has disclosed MRNA holdings in 12 of the last 12 reported quarters, going back to Q4 2023.

Latest position (Q3 2026)79.30K sh
Reported value held$15.27M
Portfolio Weight2.46%
First reportedQ4 2023
Last changeReduce
Updated2026-11-14

Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR

How Crawford Fund Management, LLC's MRNA position evolved

Crawford Fund Management, LLC first disclosed a stake in MRNA in Q4 2023 at 107,800 shares (US$10.7M). The position peaked in Q2 2024 at 137,300 shares, worth US$16.3M. Across 12 filings, Crawford Fund Management, LLC increased the stake 6 time(s), trimmed it 5 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 79,300 shares valued at US$15.3M — a reduction of -17,200 shares quarter over quarter.. Notable position changes include a 43% increase in Q3 2024 (shares fell 38% over the following quarter), a 36% trim in Q1 2026 (shares rose 38% over the following quarter), a 39% trim in Q2 2026 (shares rose 175% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2023 107.80K $10.72M New
Q1 2024 129.10K $13.76M Add
Q2 2024 137.30K $16.30M Add
Q3 2024 196.60K $13.14M Add
Q4 2024 150.60K $6.26M Reduce
Q1 2025 184.60K $5.23M Add
Q2 2025 200.10K $5.52M Add
Q3 2025 260.60K $6.73M Add
Q4 2025 247.00K $7.28M Reduce
Q1 2026 158.20K $8.04M Reduce
Q2 2026 96.50K $6.76M Reduce
Q3 2026 79.30K $15.27M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About MRNA and 13F data

MRNA (MODERNA INC) is a Health Care company. 42 other funds we track also report a position in MRNA — the largest reported positions include Fidelity Management & Research (FMR) (US$11.35B), Capital World Investors (US$4.36B), Baillie Gifford & Co (US$2.20B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding MRNA

All MRNA fund holders →

FAQ

How long has Crawford Fund Management, LLC held MRNA?

Crawford Fund Management, LLC has disclosed MRNA holdings in 12 of the last 12 reported quarters, going back to Q4 2023.

What is Crawford Fund Management, LLC's current position in MRNA?

As of Q3 2026, Crawford Fund Management, LLC holds 79.30K shares of MRNA (MODERNA INC), valued at $15.27M, representing 2.46% of its reported portfolio and ranking #8.

Has Crawford Fund Management, LLC been buying or selling MRNA?

In the latest 13F filing (Q3 2026), Crawford Fund Management, LLC reduced its position in MRNA. The position peaked in Q2 2024 at 137.30K shares.

Which other funds hold MRNA?

Other major institutional holders of MRNA include Fidelity Management & Research (FMR), Capital World Investors, Baillie Gifford & Co, among 42 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.